• Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • The average person may be well aware of the risks of alcohol, opioids and tobacco  of risk particularly to pregnant women and their unborn babies. Surgeon Generals’ warnings are now a law of the land in the U.S. But what about other hazards like persistent organic pollutants, and what about countries where chemicals in manufacturing are ubiquitous and unregulated, seeping into the groundwater? In a Maternova blog series we will be exploring the impact of environmental toxins on our populations.

    There are some 4700 chemicals just in this one category tracked by the OECD. Let’s take PFOA in the United States as an example of what happens when a chemical enters the bloodstream of an entire population. The CDC states that PFOAs “can affect growth and development, reproduction, and injure the liver.” Other studies have associated PFOAs with increased risk of preeclampsia for women. CDC scientists found PFOA in the serum i.e. the blood) of nearly all the people tested, indicating that PFOA exposure is widespread in the U.S. population.


    PFOAs are one subset of a class of chemicals widely in use in manufacturing for the last 60 years. In the case of PFOA, increasing concerns about toxicity led the government to call for voluntary phase-outs One study estimates that this phaseout prevented between 10,000 and 17,000 low-weight births in the United States, per year.

    The EPA introduced the PFOA Stewardship Program to work with companies in the U.S. as well as their global operations to phase out some of the harmful chemicals used by companies like 3M and Dupont. This brief timeline shows the results of a voluntary phase-out program:

    2003-2008 PFOA levels rose to a peak level of 3.5 nanograms per mL in US population
    2006 The U.S. EPA introduced the voluntary phase out of PFOAs by 8 major companies
    2009 The trend starts to reverse when the U.S. government began a voluntary phaseout
    2014 PFOA blood levels in the U.S. dropped to 1.6 nanograms per mL

    Most sobering are the words used in a Minnesota study of these chemicals and their ability to cross the placenta, transfer from the mother during breastfeeding or transfer from groundwater in mixed formula: bioaccumulation and transgenerational exposure. We will be following up this post with more on PFOAs, Minnesota and the rest of the world. Questions remain about how this, and other chemicals, accumulate in populations and are transferred between generations. In areas with extremely high levels of PFOA levels above normal, what does this mean for the ethics of recommending breastfeeding for all women?

    Leave a comment

    Comments will be approved before showing up.


    Also in The Maternova Blog

    MaternaWell Tray: A Simple Tool Changing How the World Measures Blood Loss at Birth, Now in 18 Countries
    MaternaWell Tray: A Simple Tool Changing How the World Measures Blood Loss at Birth, Now in 18 Countries

    March 08, 2026 3 min read

    What makes the MaternaWell Tray notable is not just its design, but its practicality. In many of the settings where maternal mortality remains highest, hospitals must make difficult choices about which technologies they can realistically maintain.  The tray is now in use in 18 countries.

    Read More
    Can a Simple Treatment Bundle Cut Maternal Sepsis Deaths?
    Can a Simple Treatment Bundle Cut Maternal Sepsis Deaths?

    February 25, 2026 2 min read

    Implementation of the APT-Sepsis program led to a significantly lower risk of a
    composite outcome of infection-related maternal death, infection-related near-miss event, or severe infection-related illness than usual care.

    Read More
    Pumani bubble CPAP for respiratory distress syndrome in children 1 to 59 months; SDG3; innovation
    Pumani bubble CPAP

    November 11, 2025 1 min read

    The Pumani bubble CPAP was engineered by a team at Rice University in Texas, working in collaboration with clinicians in Malawi.  A range of specific design considerations made the Pumani especially appropriate for low-resource settings so that parts are easy to replace. 

    Read More